{
    "medicine_id": "2297ef0a82c2f23f2ebad0fd2e9808a2facf2228",
    "platform_id": "DB15643",
    "metadata": {
        "name": "Fluzone Quadrivalent Southern Hemisphere 15 mcg Suspension",
        "composition": "15 mcg N 2 Aminoethyl 1 aziridineethanamine",
        "clinical_particulars": {
            "therapeutic_indications": "This experimental drug was being researched for its use in the treatment of cardiovascular disease and SARS CoV infections A192426",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}